Use of cannabinoids for the management of chronic cancer pain: Integrative review

Detalhes bibliográficos
Autor(a) principal: Santos, Luiz Otávio Pereira
Data de Publicação: 2022
Outros Autores: Rehem, Amanda Rodrigues, Silva, Leandro Andrade da, Scorzoni, Liliana
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/38531
Resumo: Objective: To present publications expressed in the world scientific literature on the use of cannabinoids in the management of chronic cancer pain. Method: Integrative literature review whose data search was performed using the descriptors “Medical Marijuana”, “Cannabinoids”, “Cannabis”, “Chronic Pain”, “Cancer Pain”, defined from the vocabulary of Health Sciences Descriptors ( DeCS), these terminologies were combined using the Boolean operator AND in the electronic databases: Medical Literature Analysis and Retrieval System Online (MEDLINE) and Latin American and Caribbean Literature in Health Sciences (LILACS) via the Library Virtual Health (VHL). Scientific Electronic Library Online (SciELO), Web of Science (WOS), Cinahl and Scopus via CAPES Journal Portal and Cochrane Library. Results: A total of 208 studies were identified in these databases. With 40 in Medline, 01 in LILACS, 0 in SciELO, 89 in the Scopus database, 62 in the Web of Science, 9 in the Cochrane Library and 7 in CINAHL, 27 duplicate articles were excluded, leaving 181 articles. Of these, 117 articles that did not directly address the object of this research were excluded, resulting in a final sample of 10 articles. Conclusion: There is preclinical evidence that CBD can address several of the underlying pathways of cancer, and there is preclinical and clinical evidence that CBD can be effective in treating many of the symptoms and signs associated with the disease and its orthodox treatment. , however, studies that address: administration, dosage schedules and absorption of medical cannabis in the treatment of cancer are still scarce in the literature.
id UNIFEI_e9d0c4c4ca83c3b5a4b6202a7ad81b22
oai_identifier_str oai:ojs.pkp.sfu.ca:article/38531
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Use of cannabinoids for the management of chronic cancer pain: Integrative reviewUso de cannabinoides para el tratamiento del dolor oncológico crónico: Revisión integradoraUso de canabinóides para o manejo da dor crônica oncológica: Revisão integrativaMedical MarijuanaCannabinoidsChronic painCannabisCancer pain.Marihuana MedicinalDolor crónicoCannabinoidesCannabisDolor en cáncer.Maconha MedicinalDor crônicaCanabinoidesCannabisDor do câncer.Objective: To present publications expressed in the world scientific literature on the use of cannabinoids in the management of chronic cancer pain. Method: Integrative literature review whose data search was performed using the descriptors “Medical Marijuana”, “Cannabinoids”, “Cannabis”, “Chronic Pain”, “Cancer Pain”, defined from the vocabulary of Health Sciences Descriptors ( DeCS), these terminologies were combined using the Boolean operator AND in the electronic databases: Medical Literature Analysis and Retrieval System Online (MEDLINE) and Latin American and Caribbean Literature in Health Sciences (LILACS) via the Library Virtual Health (VHL). Scientific Electronic Library Online (SciELO), Web of Science (WOS), Cinahl and Scopus via CAPES Journal Portal and Cochrane Library. Results: A total of 208 studies were identified in these databases. With 40 in Medline, 01 in LILACS, 0 in SciELO, 89 in the Scopus database, 62 in the Web of Science, 9 in the Cochrane Library and 7 in CINAHL, 27 duplicate articles were excluded, leaving 181 articles. Of these, 117 articles that did not directly address the object of this research were excluded, resulting in a final sample of 10 articles. Conclusion: There is preclinical evidence that CBD can address several of the underlying pathways of cancer, and there is preclinical and clinical evidence that CBD can be effective in treating many of the symptoms and signs associated with the disease and its orthodox treatment. , however, studies that address: administration, dosage schedules and absorption of medical cannabis in the treatment of cancer are still scarce in the literature.Objetivo: Presentar publicaciones expresadas en la literatura científica mundial sobre el uso de cannabinoides en el manejo del dolor oncológico crónico. Método: Revisión integrativa de la literatura cuya búsqueda de datos se realizó utilizando los descriptores “Medical Marijuana”, “Cannabinoids”, “Cannabis”, “Chronic Pain”, “Cancer Pain”, definidos a partir del vocabulario de Descriptores de Ciencias de la Salud (DeCS), estas terminologías se combinaron mediante el operador booleano AND en las bases de datos electrónicas: Medical Literature Analysis and Retrieval System Online (MEDLINE) y Latin American and Caribbean Literature in Health Sciences (LILACS) a través de la Biblioteca Virtual en Salud (BVS). Scientific Electronic Library Online (SciELO), Web of Science (WOS), Cinahl y Scopus a través de CAPES Journal Portal y Cochrane Library. Resultados: Se identificaron un total de 208 estudios en estas bases de datos. Con 40 en Medline, 01 en LILACS, 0 en SciELO, 89 en la base de datos Scopus, 62 en Web of Science, 9 en Cochrane Library y 7 en CINAHL, se excluyeron 27 artículos duplicados, quedando 181 artículos. De estos, se excluyeron 117 artículos que no abordaban directamente el objeto de esta investigación, resultando una muestra final de 10 artículos. Conclusión: existe evidencia preclínica de que el CBD puede abordar varias de las vías subyacentes del cáncer, y existe evidencia preclínica y clínica de que el CBD puede ser efectivo en el tratamiento de muchos de los síntomas y signos asociados con la enfermedad y su tratamiento ortodoxo. sin embargo, los estudios que abordan: la administración, los esquemas de dosificación y la absorción del cannabis medicinal en el tratamiento del cáncer aún son escasos en la literatura.Objetivo: Apresentar publicações expressas na literatura científica mundial sobre o uso do canabinóides no manejo da dor crônica oncológica. Método: Revisão integrativa de literatura cuja busca de dados foi realizada utilizando os descritores “Medical Marijuana”, “Cannabinoids”, “Cannabis”, “Chronic Pain”, “Cancer Pain”, definidas a partir do vocabulário dos Descritores em Ciências da Saúde (DeCS), essas terminologias foram combinadas entre si, utilizando-se o operador booleano AND nas bases de dados eletrônicas: Medical Literature Analysis and Retrieval System Online (MEDLINE) e Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS) via Biblioteca Virtual de Saúde (BVS). Scientific Eletronic Library Online (SciELO), Web of Science (WOS), Cinahl e Scopus via Portal de Periódicos CAPES e Cochrane Library. Resultados: Identificou-se, um total de 208 estudos nas referidas bases de dados. Sendo 40 Medline, 01 no LILACS, 0 na SciELO, 89 na base de dados Scopus, 62 no Web of Science, 9 na Cochrane Library e 7 na CINAHL, foram excluídos 27 artigos duplicados, restando 181 artigos. Destes foram excluídos 117 artigos que não tratavam diretamente do objeto desta pesquisa, resultando em uma amostra final de 10 artigos. Conclusão: Há evidências pré-clínicas de que o CBD pode abordar várias das vias subjacentes ao câncer, e há evidências pré-clínicas e clínicas de que o CBD pode ser eficaz no tratamento de vários dos sintomas e sinais associados à doença e seu tratamento ortodoxo, no entanto, ainda é escasso na literatura estudos que abordem: administração, esquemas de dosagem e absorção de cannabis medicinal no tratamento do câncer.Research, Society and Development2022-12-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3853110.33448/rsd-v11i17.38531Research, Society and Development; Vol. 11 No. 17; e13111738531Research, Society and Development; Vol. 11 Núm. 17; e13111738531Research, Society and Development; v. 11 n. 17; e131117385312525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/38531/32005Copyright (c) 2022 Luiz Otávio Pereira Santos; Amanda Rodrigues Rehem; Leandro Andrade da Silva; Liliana Scorzonihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSantos, Luiz Otávio Pereira Rehem, Amanda RodriguesSilva, Leandro Andrade daScorzoni, Liliana 2022-12-28T13:53:48Zoai:ojs.pkp.sfu.ca:article/38531Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:52:14.094979Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Use of cannabinoids for the management of chronic cancer pain: Integrative review
Uso de cannabinoides para el tratamiento del dolor oncológico crónico: Revisión integradora
Uso de canabinóides para o manejo da dor crônica oncológica: Revisão integrativa
title Use of cannabinoids for the management of chronic cancer pain: Integrative review
spellingShingle Use of cannabinoids for the management of chronic cancer pain: Integrative review
Santos, Luiz Otávio Pereira
Medical Marijuana
Cannabinoids
Chronic pain
Cannabis
Cancer pain.
Marihuana Medicinal
Dolor crónico
Cannabinoides
Cannabis
Dolor en cáncer.
Maconha Medicinal
Dor crônica
Canabinoides
Cannabis
Dor do câncer.
title_short Use of cannabinoids for the management of chronic cancer pain: Integrative review
title_full Use of cannabinoids for the management of chronic cancer pain: Integrative review
title_fullStr Use of cannabinoids for the management of chronic cancer pain: Integrative review
title_full_unstemmed Use of cannabinoids for the management of chronic cancer pain: Integrative review
title_sort Use of cannabinoids for the management of chronic cancer pain: Integrative review
author Santos, Luiz Otávio Pereira
author_facet Santos, Luiz Otávio Pereira
Rehem, Amanda Rodrigues
Silva, Leandro Andrade da
Scorzoni, Liliana
author_role author
author2 Rehem, Amanda Rodrigues
Silva, Leandro Andrade da
Scorzoni, Liliana
author2_role author
author
author
dc.contributor.author.fl_str_mv Santos, Luiz Otávio Pereira
Rehem, Amanda Rodrigues
Silva, Leandro Andrade da
Scorzoni, Liliana
dc.subject.por.fl_str_mv Medical Marijuana
Cannabinoids
Chronic pain
Cannabis
Cancer pain.
Marihuana Medicinal
Dolor crónico
Cannabinoides
Cannabis
Dolor en cáncer.
Maconha Medicinal
Dor crônica
Canabinoides
Cannabis
Dor do câncer.
topic Medical Marijuana
Cannabinoids
Chronic pain
Cannabis
Cancer pain.
Marihuana Medicinal
Dolor crónico
Cannabinoides
Cannabis
Dolor en cáncer.
Maconha Medicinal
Dor crônica
Canabinoides
Cannabis
Dor do câncer.
description Objective: To present publications expressed in the world scientific literature on the use of cannabinoids in the management of chronic cancer pain. Method: Integrative literature review whose data search was performed using the descriptors “Medical Marijuana”, “Cannabinoids”, “Cannabis”, “Chronic Pain”, “Cancer Pain”, defined from the vocabulary of Health Sciences Descriptors ( DeCS), these terminologies were combined using the Boolean operator AND in the electronic databases: Medical Literature Analysis and Retrieval System Online (MEDLINE) and Latin American and Caribbean Literature in Health Sciences (LILACS) via the Library Virtual Health (VHL). Scientific Electronic Library Online (SciELO), Web of Science (WOS), Cinahl and Scopus via CAPES Journal Portal and Cochrane Library. Results: A total of 208 studies were identified in these databases. With 40 in Medline, 01 in LILACS, 0 in SciELO, 89 in the Scopus database, 62 in the Web of Science, 9 in the Cochrane Library and 7 in CINAHL, 27 duplicate articles were excluded, leaving 181 articles. Of these, 117 articles that did not directly address the object of this research were excluded, resulting in a final sample of 10 articles. Conclusion: There is preclinical evidence that CBD can address several of the underlying pathways of cancer, and there is preclinical and clinical evidence that CBD can be effective in treating many of the symptoms and signs associated with the disease and its orthodox treatment. , however, studies that address: administration, dosage schedules and absorption of medical cannabis in the treatment of cancer are still scarce in the literature.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-18
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/38531
10.33448/rsd-v11i17.38531
url https://rsdjournal.org/index.php/rsd/article/view/38531
identifier_str_mv 10.33448/rsd-v11i17.38531
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/38531/32005
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 17; e13111738531
Research, Society and Development; Vol. 11 Núm. 17; e13111738531
Research, Society and Development; v. 11 n. 17; e13111738531
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052838035062784